Advertisement
Screener

Lumexa Imaging Holdings, Inc. (LMRI) Overview

Lumexa Imaging Holdings, Inc. (LMRI) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 0.03; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 0.02; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.10; Beat / miss (m).
  • 1 Jan 2025: Period ending 31 Mar 2025; Estimate (m); Actual -0.11; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$6.43$8.03$10.01$12.50$15.59$19.462025-12-112026-11-06$6.43$8.03$10.01$12.50$15.59$19.462025-12-112026-11-06$6.43$8.03$10.01$12.50$15.59$19.462025-12-112026-11-06$6.43$8.03$10.01$12.50$15.59$19.462025-12-112026-11-06$6.43$8.03$10.01$12.50$15.59$19.462025-12-112026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$13.41
Previous close
$10.26
Change
$3.15
Change (%)
30.70%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

LMRI
-44.54%
S&P 500
(m)

1 year

LMRI
(m)
S&P 500
(m)

3 years

LMRI
(m)
S&P 500
(m)

5 years

LMRI
(m)
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 0.03

-0.19-0.090.010.110.2131 Mar 2025: estimate (m); actual -0.1131 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.1030 Jun 2025(m)31 Mar 2026: estimate (m); actual 0.0231 Mar 2026(m)30 Jun 2026: estimate (m); actual 0.0330 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)0.03(m)(m)
1 Jan 202631 Mar 2026(m)0.02(m)(m)
1 Apr 202530 Jun 2025(m)-0.10(m)(m)
1 Jan 202531 Mar 2025(m)-0.11(m)(m)

(m)

Comparison details
Period startPeriod endingEstimateActualBeat / missReport date

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 264.16M ■ Earnings 2.75M — Profit margin 1.04%

-40.31M-4.1%72.06M-2.1%184.42M-0.0%296.78M2.0%31 Mar 2025: revenue 245.00M; earnings -7.69M; profit margin -3.14%31 Mar 202530 Jun 2025: revenue 251.40M; earnings -7.23M; profit margin -2.87%30 Jun 202531 Mar 2026: revenue 252.54M; earnings 1.72M; profit margin 0.68%31 Mar 202630 Jun 2026: revenue 264.16M; earnings 2.75M; profit margin 1.04%30 Jun 2026

No complete retained periods.

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$13.41(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$13.41High(m)Average(m)Low(m)2025-12-112026-11-06

Recent news

View more →

(m)

YouTube videos mentioning LMRI

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
382.15K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-2.47%*
Total return · month
-10.86%*
Total return · quarter
-10.63%*
Total return · half year
31.71%*
Total return · year to date
-44.54%*
Total return · 1 year
(m)
Total return · 3 years
(m)
Total return · 5 years
(m)
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
135.61%*
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Lumexa Imaging Holdings, Inc. Overview

View more →

(m)

(m)

SEC CIK
2071288
Industry (SIC)
8071 Services-Medical Laboratories
Country of operation
United States
Business address
4200 SIX FORKS ROAD, SUITE 1000, RALEIGH, North Carolina, 27609, United States
Fiscal year end
1231
Phone
704-334-7830

Similar stocks

Stock NameCountryMarket CapPE Ratio
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
Personalis, Inc. (PSNL)United States$1.769B-13.30
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B